Not every method is expected to demonstrate every validation characteristic uniformly
Fatigue is a prevalent and debilitating symptom experienced by many people with multiple sclerosis (MS), yet it remains difficult to define and measure
A systematic review and meta-analysis [162] that looked at 18 randomized controlled trials concluded that: 1
On the other hand, a study with a different design, namely a randomized, double-blind, placebo-controlled crossover comparison clinical trial, and partially different cohort and methodologies demonstrated that daily oral administration of very low doses (1.5 g/day) of l-ARG for a very short time (17 days) did not improve patients satisfaction with their penile erectile function and their sexual life, analyzed by the standardized KEED questionnaire for ED, in 30 middle-aged men affected by ED of mixed etiology and severity [29], suggesting that higher doses and longer-term supplementation might be required, or that l-ARG might be of particular benefit in subtypes of ED, such as those of vasculogenic etiology
Sulforaphane ameliorates neurobehavioral deficits and protects the brain from amyloid deposits and peroxidation in mice with Alzheimer-like lesions
